These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34261306)

  • 1. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy.
    Wang X; Gu H; Zhang H; Xian J; Li J; Fu C; Zhang C; Zhang J
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33948-33961. PubMed ID: 34261306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of hyaluronic acid-functionalized magnolol nanoparticles for ulcerative colitis treatment.
    Li Y; Chen T; Chen L; Wu D; Hu J
    Int J Biol Macromol; 2024 May; 268(Pt 2):131920. PubMed ID: 38679261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-functionalized DDAB/PLGA nanoparticles for improved oral delivery of magnolol in the treatment of ulcerative colitis.
    Li W; Lin J; Zhou J; He S; Wang A; Hu Y; Li H; Zou L; Liu Y
    Int J Pharm; 2024 Mar; 653():123878. PubMed ID: 38325622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnolol treatment attenuates dextran sulphate sodium-induced murine experimental colitis by regulating inflammation and mucosal damage.
    Shen P; Zhang Z; He Y; Gu C; Zhu K; Li S; Li Y; Lu X; Liu J; Zhang N; Cao Y
    Life Sci; 2018 Mar; 196():69-76. PubMed ID: 29355546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
    Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
    Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
    Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
    J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis.
    Naeem M; Lee J; Oshi MA; Cao J; Hlaing SP; Im E; Jung Y; Yoo JW
    Acta Biomater; 2020 Oct; 116():368-382. PubMed ID: 32937207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis.
    Wang A; Liu Y; Xiong W; Li W; Li J; Yang Z; Zou Z; Luo Y; Chen Z; Li H; Vong CT; Zou L
    J Pharm Sci; 2024 Sep; 113(9):2744-2755. PubMed ID: 38901529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
    Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
    Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Functional Eudragit
    Gao C; Yu S; Zhang X; Dang Y; Han DD; Liu X; Han J; Hui M
    Int J Nanomedicine; 2021; 16():1405-1422. PubMed ID: 33658780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles.
    Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B
    Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel.
    Lee HS; Kang NW; Kim H; Kim DH; Chae JW; Lee W; Song GY; Cho CW; Kim DD; Lee JY
    Carbohydr Polym; 2021 Feb; 253():117187. PubMed ID: 33278965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon tissue-accumulating mesoporous carbon nanoparticles loaded with
    Zhang L; Gui S; Xu Y; Zeng J; Wang J; Chen Q; Su L; Wang Z; Deng R; Chu F; Liu W; Jin X; Lu X
    Theranostics; 2021; 11(7):3417-3438. PubMed ID: 33537095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis.
    Ali AS; Altayari AA; Khan LM; Alharthi SE; Ahmed OA; El-Shitany NA; Ali SS; Saadah OI
    Pharmacology; 2020; 105(9-10):541-549. PubMed ID: 31940656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
    Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
    Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment.
    Luo R; Lin M; Fu C; Zhang J; Chen Q; Zhang C; Shi J; Pu X; Dong L; Xu H; Ye N; Sun J; Lin D; Deng B; McDowell A; Fu S; Gao F
    Carbohydr Polym; 2021 Jul; 263():117998. PubMed ID: 33858583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine and magnolol exert cooperative effects on ulcerative colitis in mice by self-assembling into carrier-free nanostructures.
    Xu Y; Chen Z; Hao W; Yang Z; Farag M; Vong CT; Wang Y; Wang S
    J Nanobiotechnology; 2024 Sep; 22(1):538. PubMed ID: 39227962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
    Xiao B; Si X; Zhang M; Merlin D
    Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitis.
    Wu Y; Sun M; Wang D; Li G; Huang J; Tan S; Bao L; Li Q; Li G; Si L
    Biomater Sci; 2019 Oct; 7(10):4299-4309. PubMed ID: 31408067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.
    Gou S; Huang Y; Wan Y; Ma Y; Zhou X; Tong X; Huang J; Kang Y; Pan G; Dai F; Xiao B
    Biomaterials; 2019 Aug; 212():39-54. PubMed ID: 31103945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.